id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-320632-369kax2m	Song, Yang	COVID-19 Treatment: Close to a Cure? – A Rapid Review of Pharmacotherapies for the Novel Coronavirus	2020-07-04		.txt	text/plain	5659	335	45	The selection of medications in this review is based the 7 th edition of COVID-19 diagnosis and treatment guideline issued by the National Health Commission (NHC) of the People's Republic of China ( Table 2) and relevant clinical studies. In a phase 2 open-label COVID-19 trial, which enrolled 127 patients from 6 Hong Kong hospitals, Hung and his colleagues compared triple therapy (lopinavir/ritonavir 400/100 mg PO every 12 hours, ribavirin 400 mg PO every 12 hours, and interferon β-1b 8 million IU SQ on alternative days) with a control group of LPV/r [33] . During the 2013 SARS epidemic, observational studies and case reports described IVIG for the treatment of critically ill patients in combination with antiviral therapies. In a COVID-19 case series study, the combination of umifenovir, lopinavir/ritonavir and traditional Chinese medicine alleviated pneumonia symptoms in all four patients and decreased viral load to undetectable in two [68] .	./cache/cord-320632-369kax2m.txt	./txt/cord-320632-369kax2m.txt